Dr. Bizzell Speaks About the First FDA-Approved Treatment for Ebola

Dr. Anton C. Bizzell shares his insights in the Verywell Health article, “Regeneron Earns First-Ever FDA Approval For Ebola Treatment,” about the U.S. Food and Drug Administration (FDA) approval of Inmazeb, an antibody cocktail designed to treat the Ebola virus. A mixture of three monoclonal antibodies administered via injection is the first FDA-approved treatment for the virus. The drug is manufactured by Regeneron, the same company behind the antibody cocktail aimed at treating COVID-19. The Bizzell Group (Bizzell) has been on the ground fighting the Ebola virus in the Democratic Republic of Congo. “The approval of Inmazeb is not only a big deal, it is the approach to prevent a future Ebola pandemic worldwide,” Dr. Bizzell tells Verywell.

READ MORE: Regeneron Earns First-Ever FDA Approval For Ebola Treatment

Lessons for COVID-19 Recovery From the Ebola Epidemic

Lessons for COVID-19 Recovery From the Ebola Epidemic

In a recent Psychology Today article, Dr. Anton C. Bizzell highlights some of the lessons The Bizzell Group (Bizzell) learned during the most recent Ebola virus epidemic. Bizzell partnered with local, national, and international groups to improve health outcomes and mental health consequences in the Democratic Republic of Congo. These lessons can help address the global mental health crisis already emerging due to COVID-19.
“We cannot focus solely on the transmission of COVID-19,” Dr. Bizzell writes. “We must formulate an innovative and sustainable response that addresses the global mental health crisis already emerging.”

READ MORE: Lessons for COVID-19 Recovery From the Ebola Epidemic

Bizzell Launches Behavioral Health Advancement Resource Center to Aid Behavioral Health Priorities (BHARC)

Bizzell Launches Behavioral Health Advancement Resource Center to Aid Behavioral Health Priorities (BHARC)

August 10, 2020 (Lanham, MD)The Bizzell Group (Bizzell), an award-winning strategy, technology, and consulting services firm with a passion for improving lives, today announced the launch of the Behavioral Health Advancement Resource Center (BHARC). This new site presents innovative solutions for organizations of all sizes, in business, governmental agencies, and non-governmental organizations to some of the most critical issues affecting the well-being of the human race today. Chief among these issues are the opioid epidemic, substance use disorders and suicide prevention.

The increasing number of COVID-19 cases nationally and around the globe has heightened concerns about mental health and substance abuse and misuse issues. With stay-at-home restrictions, social isolation, and fear of contracting the virus as contributing factors for increased anxiety, attention to mental health is of greater importance than ever. This is especially true in lower socioeconomic areas where resources are limited. BHARC will serve as a valuable source of solutions to improve and maintain community health and well-being across the United States and around the world.

BHARC provides the following tools:

  • Subject matter expertise on the areas of substance use, mental health, vulnerable populations, HIV and AIDS, tobacco research, suicide prevention, maternal and child health and social behavior change
  • Technical assistance, trainings and innovative tools
  • News, media and industry insights

BHARC developed as a result of Bizzell’s work over the years within the federal health space, including:

  • U.S. Department of Health and Human Services (HHS)
  • Centers for Disease Control and Prevention (CDC)
  • Centers for Medicare & Medicaid Services (CMS)
  • Food and Drug Administration (FDA)
  • National Institutes of Health (NIH)
  • Office on Women’s Health (OWH)
  • Substance Abuse and Mental Health Services Administration (SAMHSA)
  • United States Agency for International Development (USAID)
  • U.S. Department of Defense (DoD)
  • U.S. Department of Labor (DOL)

“At Bizzell, we are accelerating advancements in behavioral health, working with clients and agencies to prioritize prevention,” said Anton C. Bizzell M.D., CEO and President of The Bizzell Group. “Many communities are disproportionately affected and change needs to start from within the public health spectrum. This includes taking initiative on how we can provide resources to better improve clinical medicine, community health and maternal and child health so that we build healthy, secure and connected communities around our nation and around the world.”

For more information on The Bizzell Group’s Behavioral Health Advancement Resource Center or to sign up for the newsletter, please go to https://www.bharc.org

About The Bizzell Group

Established in 2010, The Bizzell Group (Bizzell) is a U.S. Small Business Administration (SBA) 8(a) certified strategy, consulting, and technology firm that specializes in program management, administrative support, communications and outreach, conference management and logistical support, health services and research, technical assistance, and training and development. Bizzell’s expert staff and consultants work on health, scientific, education, environmental, research, and information technology projects that advance national priorities. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown from a staff of two in one small office, to a thriving firm with four offices in Lanham, MD, Rockville, MD, Atlanta, GA and the Democratic Republic of the Congo, with ongoing projects around the world. Learn more about how we develop data-driven, research-informed, innovative solutions to complex-real-world challenges: The Bizzell Group.

BIZZELL AWARDED USAID EVAL MEL II IDIQ

BIZZELL AWARDED USAID EVAL MEL II IDIQ

July 13, 2020 (Lanham, MD) The Bizzell Group (Bizzell) was awarded a prime contract under the United States Agency for International Development (USAID) Bureau for Policy, Planning, and Learning Office of Learning, Evaluation, and Research (PPL/LER) to provide monitoring, evaluation and learning (MEL) services through the EVAL ME II IDIQ. This work is aimed at strengthening USAID’s evidence-based decision making by providing high quality and timely MEL services.

“It is an honor to know that our MEL work is trusted and valued by an esteemed agency such as USAID,” says Rose Amolo, Director of Global Programs at Bizzell. “We look forward to bringing a new and unique perspective to the program as we leverage our staff’s expertise and insights to support USAID’s MEL efforts around the world.”

Under this new contract, Bizzell will design and implement quantitative and qualitative evaluation studies and assessments; conduct evaluation synthesis or synthetic reviews; provide technical assistance in performance monitoring; provide monitor services, develop and deliver evaluation and monitor training; support the agency in learning from evidence to adapt programming; and support implementation of knowledge management practices and services.

Bizzell is joined by MEL practitioners, QED Group and NORC, as sub-contractors on the opportunity.

About The Bizzell Group

Established in 2010, The Bizzell Group (Bizzell) is a U.S. Small Business Administration 8(a) certified strategic management consulting firm. Our expert staff and consultants work on Monitoring & Evaluation, Communication & Outreach, Data Analytics, Global Services, Health Information Solutions, Innovation & Technology, Program Management, and Workforce Innovation projects that meet national priorities. Under the leadership and vision of founder, Anton C. Bizzell, MD, the company has grown from a staff of two in one small office, to a thriving firm with offices in Lanham, MD; Rockville, MD; Atlanta, GA; and the Democratic Republic of the Congo, with ongoing projects around the world. Learn more about our data-driven, research-informed, innovative solutions to complex-real-world challenges: The Bizzell Group.